Nanotechnology for enrichment and detection of circulating tumor cells

被引:9
作者
Bhana, Saheel [1 ]
Wang, Yongmei [1 ]
Huang, Xiaohua [1 ]
机构
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
关键词
circulating tumor cells; detection; enrichment; functional nanoparticles; microfluidics; nanostructured substrates; nanotechnology; METASTATIC BREAST-CANCER; IRON-OXIDE NANOPARTICLES; IN-VIVO; FLOW-CYTOMETRY; EFFICIENT CAPTURE; PERIPHERAL-BLOOD; QUANTUM DOTS; SEMICONDUCTOR NANOCRYSTALS; MOLECULAR CHARACTERIZATION; SENSITIVE DETECTION;
D O I
10.2217/NNM.15.32
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Circulating tumor cells (CTCs) are a hallmark of invasive behavior of cancer, responsible for the development of metastasis. Their detection and analysis have significant impacts in cancer biology and clinical practice. However, CTCs are rare events and contain heterogeneous subpopulations, requiring highly sensitive and specific techniques to identify and capture CTCs with high efficiency. Nanotechnology shows strong promises for CTC enrichment and detection owning to the unique structural and functional properties of nanoscale materials. In this review, we discuss the CTC enrichment and detection technologies based on a variety of functional nanosystems and nanostructured substrates, with the goal to highlight the role of nanotechnology in the advancement of basic and clinical CTC research.
引用
收藏
页码:1973 / 1990
页数:18
相关论文
共 139 条
[1]   Integrated acoustic and magnetic separation in microfluidic channels [J].
Adams, Jonathan D. ;
Thevoz, Patrick ;
Bruus, Henrik ;
Soh, H. Tom .
APPLIED PHYSICS LETTERS, 2009, 95 (25)
[2]  
Aguilar ZP, 2012, NANOMATERIALS MED AP, P544
[3]   Technologies for detection of circulating tumor cells: facts and vision [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
LAB ON A CHIP, 2014, 14 (01) :57-62
[4]   Circulating Tumor Cells: Liquid Biopsy of Cancer [J].
Alix-Panabieres, Catherine ;
Pantel, Klaus .
CLINICAL CHEMISTRY, 2013, 59 (01) :110-118
[5]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[6]   Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system [J].
Andreopoulou, E. ;
Yang, L. -Y. ;
Rangel, K. M. ;
Reuben, J. M. ;
Hsu, L. ;
Krishnamurthy, S. ;
Valero, V. ;
Fritsche, H. A. ;
Cristofanilli, M. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (07) :1590-1597
[7]  
[Anonymous], SCI REP
[8]   Enrichment, detection and clinical significance of circulating tumor cells [J].
Arya, Sunil K. ;
Lim, Bing ;
Rahman, Abdur Rub Abdur .
LAB ON A CHIP, 2013, 13 (11) :1995-2027
[9]  
Ashworth T., 1869, AUST MED J, V14, P146
[10]  
Balic M, 2012, EXPERT REV MOL DIAGN, V12, P303, DOI [10.1586/erm.12.12, 10.1586/ERM.12.12]